Skip to main content

ABVC BioPharma, Inc.

corporate_fare Company Profile

ABVC BioPharma, Inc.

ABVC·NASDAQ·Life Sciences·CIK 0001173313

ABVC is an early-stage biotechnology company focused on developing new drugs and one medical device. The company has a pipeline of seven new drugs and one medical device under development, all licensed from related parties. ABVC aims to provide therapeutic solutions for unmet medical needs and improve human health by developing innovative botanical drugs to treat central nervous system (CNS) and oncology/hematology diseases. As of the date of this report, ABVC's revenue is generated from outlicensing its intellectual properties and providing CDMO services. The company develops its product pipeline by tracking new medical discoveries or medical device technologies in research institutions within the Asia-Pacific region. ABVC's scientists and specialists examine pre-clinical, disease animal model, and Phase I safety studies to identify drugs or medical devices that demonstrate efficacy and safety based on internal qualifications. Once a drug or medical device is deemed a good candidate for further development and commercialization, ABVC licenses it from the original researchers and introduces the clinical trial plan to principal investigators in the United States, Australia, and Taiwan.

ABVC BioPharma, Inc. (NASDAQ:ABVC) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 16 items for ABVC at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 16 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for ABVC spans S-3/A, 10-Q, 8-K, DEF 14A.

Recent high-impact activity:

  • ABVC Amends $100M Shelf Registration While Cash Stands at $11,294
  • ABVC Q3 10-Q: $11,294 Cash, $5.79M Working Capital Deficit, Going-Concern Doubt
  • ABVC Closes $3.39M Discounted Convertible Note Deal and Settles Lind Litigation for $625,000
  • ABVC Closes $3.39M OID Note Sale With 15% Conversion Discount and $625K Settlement Payout
  • ABVC Sets October 28 Vote on 5.2M-Share Equity Plan and Related-Party Land Deal

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$296K
Net Income
-$7.91M
Diluted EPS
-$0.39
Op. Cash Flow
-$2.99M
Operating Income
-$7.15M
Cash & Equivalents
$681.48K
Total Debt
$755.51K
Debt / Equity
0.07×
Net Margin
-26.72×
Shares Outstanding
25.05M sh
Source: 10-K · filed 2026-03-03 · accession 0001213900-26-023063

Short Interest & Short Volume

19.90 days to cover

FINRA reported short interest of 602,938 shares in ABVC as of the October 30, 2026 settlement, a 2.2% increase from the prior period — about 19.9 days to cover at its recent average daily volume. On November 20, 2026, 22.1% of ABVC volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)602,938 shares as of October 30, 2026
Change vs prior period▲ 2.2%
Days to cover19.90 at avg daily volume of 30,302
Daily short volume (FINRA facilities)22.1% of 23,097 shares on November 20, 2026
5-day average short volume14.0%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for ABVC, detected from its recent SEC filings · based on capital-structure filings through 2026-11-13.

2 recent capital raises

Prospectus Supplement Incorporates Q3 10-Q · Going-Concern and Liquidity Unchanged

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with A →
$0.90 +3.89% today
52-week range · as of 2026-11-10 $0.7069 – $3.06
Market cap
$23.37M
Volume
39.1K (0.9× avg)
3-mo avg 42.1K
Live data · 2026-11-21 14:54 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ABVC - Latest Insights

ABVC
Nov 10, 2026, 6:20 PM EST
Filing Type: S-3/A
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.900 info
Change: -$0.100 (-10%) info
Market Cap: $23.37M info
ABVC
Nov 10, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.900 info
Change: -$0.100 (-10%) info
Market Cap: $23.37M info
ABVC
Nov 02, 2026, 9:51 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.05
Real-time Price: $0.900 info
Change: -$0.1499 (-14%) info
Market Cap: $23.37M info
ABVC
Nov 02, 2026, 9:30 AM EST
Source: EQS
Importance Score:
7
Price at Filing: $1.04
Real-time Price: $0.900 info
Change: -$0.140 (-13%) info
Market Cap: $23.37M info
ABVC
Sep 29, 2026, 12:22 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $0.900 info
Change: -$0.130 (-13%) info
Market Cap: $23.37M info
ABVC
Sep 11, 2026, 4:30 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $1.01
Real-time Price: $0.900 info
Change: -$0.110 (-11%) info
Market Cap: $23.37M info
ABVC
Aug 27, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.740
Real-time Price: $0.900 info
Change: +$0.160 (+22%) info
Market Cap: $23.37M info
ABVC
Aug 25, 2026, 4:30 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $0.7999
Real-time Price: $0.900 info
Change: +$0.1001 (+13%) info
Market Cap: $23.37M info
ABVC
Aug 12, 2026, 5:00 PM EDT
Filing Type: PRER14A
Importance Score:
8
Price at Filing: $0.9601
Real-time Price: $0.900 info
Change: -$0.0601 (-6%) info
Market Cap: $23.37M info
ABVC
Aug 12, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.9601
Real-time Price: $0.900 info
Change: -$0.0601 (-6%) info
Market Cap: $23.37M info
ABVC
Jul 28, 2026, 4:31 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.900 info
Change: -$0.160 (-15%) info
Market Cap: $23.37M info
ABVC
May 18, 2026, 7:22 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.09
Real-time Price: $0.900 info
Change: -$0.190 (-17%) info
Market Cap: $23.37M info
ABVC
Mar 27, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.900 info
Change: -$0.100 (-10%) info
Market Cap: $23.37M info
ABVC
Mar 05, 2026, 4:29 PM EST
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.41
Real-time Price: $0.900 info
Change: -$0.510 (-36%) info
Market Cap: $23.37M info
ABVC
Feb 05, 2026, 5:29 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.30
Real-time Price: $0.900 info
Change: -$0.400 (-31%) info
Market Cap: $23.37M info
ABVC
Jan 16, 2026, 4:30 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $0.900 info
Change: -$1.10 (-55%) info
Market Cap: $23.37M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets